Replies to post #620242 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

When 50-65% gets cured, it sure seems you are wrong ... again.

The arm with ATl-DC and PolyIC had 4 patients (out of 9) live over 51 months. Not sure how it is that you consider 1 or 2 of the dead patients "cured".

And this is a trial that included lower grade gliomas. Wonder how many of those 4 did not have GBM?

ATL-DC by itself had only one patient live over 12 months.